Mechanistic insights into lactate-driven pathogenesis in diabetic kidney disease
A narrative review assembles preclinical evidence that lactate signaling and lysine lactylation may connect metabolic reprogramming, inflammation and fibrosis in ...
A narrative review assembles preclinical evidence that lactate signaling and lysine lactylation may connect metabolic reprogramming, inflammation and fibrosis in ...
A 346-publication analysis finds rapidly expanding research on SGLT2 inhibitors across cancer safety, antitumor mechanisms, real-world outcomes and cardio-oncology, but ...
A meta-analysis of three randomized trials found modest reductions in functional mitral regurgitation with SGLT2 inhibitors, but fragile results and ...
A 16-patient retrospective cohort found an association between finerenone initiation and lower urine albumin-to-creatinine ratio over six months, without detected ...
A retrospective study of 150 Chinese heart-failure patients found that adding dapagliflozin to sacubitril-valsartan was associated with better cardiac-function measures, ...
A cross-sectional survey of 382 Jordanian community pharmacists found reported gaps in knowledge about approved weight-management indications and frequent prescriptionless ...
Three-hour pretreatment with empagliflozin reduced multiple electrophysiological signs of arrhythmia in isolated mouse and rabbit heart cells from two non-ischemic ...
A new integrative review synthesizes 31 human studies showing how transporter, enzyme and target gene variants shape individual responses to ...
A matched real-world study finds that SGLT2 inhibitors in kidney transplant recipients deliver modest weight loss and stable potassium without ...
A new review argues that the longevity enzyme sirtuin 1 sits at the molecular crossroads between cellular senescence and heart ...
A randomized clinical trial shows that four weeks of canagliflozin treatment significantly reduces pancreatic beta-cell responsiveness to glucose in insulin-dysregulated ...
A new viewpoint in eClinicalMedicine argues that cardiorenal trials should routinely report absolute risk reduction and number needed to treat ...
A real-world study of 9000 patients with type 2 diabetes in China used cluster analysis to identify three clinical phenotypes ...
A four-year cohort study found that diabetes care during the COVID-19 pandemic shifted durably toward telemedicine and intensified drug therapy ...
A new study links SGLT2 inhibitor therapy with reduced circulating activin A, improved right-heart function, and modulation of BMP/activin signaling ...
A Swedish population-based study of adults aged 75 and older with type 2 diabetes finds that advanced chronic kidney disease ...
A new observational study from Türkiye found no statistically significant association between SGLT2 inhibitor use and DEXA-derived bone health outcomes ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.